Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of …
Aim Primary prophylactic implantable cardioverter defibrillators (ICDs) have demonstrated a
clear all-cause mortality benefit in patients with ischaemic cardiomyopathy, with less …
clear all-cause mortality benefit in patients with ischaemic cardiomyopathy, with less …
[引用][C] Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of …
J Romero, JC Díaz, M Grushko, R Quispe, D Briceno… - EP Europace, 2017 - cir.nii.ac.jp
Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in
non-ischaemic cardiomyopathy: results from a meta-analysis of prospective randomized …
non-ischaemic cardiomyopathy: results from a meta-analysis of prospective randomized …
[PDF][PDF] Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of …
J Romero, JC Dıaz, M Grushko, R Quispe, D Briceno… - therapy - academia.edu
Aim Primary prophylactic implantable cardioverter defibrillators (ICDs) have demonstrated a
clear all-cause mortality benefit in patients with ischaemic cardiomyopathy, with less …
clear all-cause mortality benefit in patients with ischaemic cardiomyopathy, with less …
Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of …
J Romero, JC Díaz, M Grushko, R Quispe… - EP …, 2018 - academic.oup.com
Aim Primary prophylactic implantable cardioverter defibrillators (ICDs) have demonstrated a
clear all-cause mortality benefit in patients with ischaemic cardiomyopathy, with less …
clear all-cause mortality benefit in patients with ischaemic cardiomyopathy, with less …
Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of …
J Romero, JC Díaz, M Grushko… - … : journal of the …, 2018 - pubmed.ncbi.nlm.nih.gov
Aim Primary prophylactic implantable cardioverter defibrillators (ICDs) have demonstrated a
clear all-cause mortality benefit in patients with ischaemic cardiomyopathy, with less …
clear all-cause mortality benefit in patients with ischaemic cardiomyopathy, with less …
Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of …
J Romero, JC Díaz, M Grushko, R Quispe… - … : Journal of the …, 2018 - europepmc.org
Aim: Primary prophylactic implantable cardioverter defibrillators (ICDs) have demonstrated a
clear all-cause mortality benefit in patients with ischaemic cardiomyopathy, with less …
clear all-cause mortality benefit in patients with ischaemic cardiomyopathy, with less …
Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of …
J Romero, JC Díaz, M Grushko… - … : journal of the …, 2018 - einstein.elsevierpure.com
Aim: Primary prophylactic implantable cardioverter defibrillators (ICDs) have demonstrated a
clear all-cause mortality benefit in patients with ischaemic cardiomyopathy, with less …
clear all-cause mortality benefit in patients with ischaemic cardiomyopathy, with less …